Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathological and Molecular Spectrum of Ewing Sarcomas/PNETs, Including Validation of EWSR1 Rearrangement by Conventional and Array FISH Technique in Certain Cases

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Over the years, a wide clinicopathological spectrum has been identified within Ewing family of tumors (EFTs). As these tumors are chemosensitive, their correct and timely identification is necessary. The aims of this study were (1) to present the diverse clinicopathological and molecular profile of EFTs in our settings, (2) to identify a pragmatic approach for diagnosing EFTs, especially for application of ancillary techniques, namely RT-PCR for specific transcripts (EWS-FLI1, EWS-ERG) and FISH for EWSR1 gene rearrangement, in certain cases and (3) to show the utility of tissue microarray in establishing a new FISH test. Fifty-eight EFTs were identified in 38 males and 20 females within an age-range of 1–65 years (median, 16), mostly in lower extremities (14) (24.1 %). Therapeutically, most patients underwent neoadjuvant chemotherapy with subsequent surgery. Histopathologically, diagnosis of EFTs was initially offered in 41/58 (70.6 %) tumors. On review, 59 % tumors showed diffuse pattern, while 41 % displayed rosettes. Immunohistochemically, tumor cells were mostly diffusely positive for CD99 (48/52) (92.3 %); FLI-1 (17/18) (94.4 %); variably for BCL2 (16/18) (88.8 %), synaptophysin (6/20) (35 %), S100-P (2/7) (28.5 %), CD56 (2/5) (40 %), NSE (2/5) (40 %), calponin (3/4) (75 %), EMA (5/24) (20.8 %) and CK (3/24) (12.5 %), the latter two mostly focally. Fifty five tumors were EWS-FLI1 positive, while a single tumor was EWS-ERG positive. Sensitivity for PCR was 61 %. EWSR1 rearrangement was detected by FISH in 12/13 Ewing sarcomas/PNETs. Sensitivity for EWSR1 test was 92.3 % and specificity was 100 %. Thirty-eight tumors, including 14 molecular confirmed EFTs and 21 other tumors were tested for EWSR1 rearrangement. Among 21 unrelated tumors, EWSR1 rearrangement was detected in few myoepithelial tumors, occasional desmoplastic small round cell tumor and an extraskeletal myxoid chondrosarcoma. Further, a tissue microarray with a separate set of 8 EFTs, confirmed at another laboratory was analysed for validation of EWSR1 rearrangement test. 23/28 (82.1 %) tissue cores of the tissue microarray, stained by FISH were interpretable, including EWSR1 rearrangement, detected in 20/28 tissue cores; not detected in 3 liver cores and uninterpretable in 5 (17.8 %) cores. Classical EFTs can be diagnosed with diffuse, membranous CD99 positivity, intranuclear FLI1 positivity and LCA negativity in malignant round cells. In unconventional cases, it is indispensable to reveal the concomitant fusion m-RNA by RT-PCR. In case of negative molecular results, it is necessary to prove EWSR1 rearrangement by FISH. These tests should be interpreted with clinicopathological correlation. Tissue microarrays for FISH are useful during validation of a new test, especially when sarcomas like EFTs show less genetic heterogeneity within tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G (1994) The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299

    Article  CAS  PubMed  Google Scholar 

  2. Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM (2008) Pediatric solid tumors: Ewing’s sarcoma family tumors. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Abeloff’s clinical oncology, 4th edn. Elsevier, Philadelphia, pp 2085–2091

    Google Scholar 

  3. Khoury JD (2005) Ewing sarcoma family of tumors. Adv Anat Pathol 12:212–220

    Article  PubMed  Google Scholar 

  4. Ushigome S, Machinami R, Sorensen PH (2002) Ewing sarcoma/Primitive neuroectodermal tumor. In: Fletcher CDM, Unni K, Mertens F (eds) Tumors of soft tissue and bone. Pathology and genetics. World Health Organization classification of tumors. IARC Press, Lyon, pp 298–300

    Google Scholar 

  5. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A (1983) Translocation of chromosome 22 in Ewing’s sarcoma. C R Seances Acad Sci III 296:1105–1107

    CAS  PubMed  Google Scholar 

  6. Aurias A, Rimbaut C, Buffe D, Zucker JM, Mazabraud A (1984) Translocation involving chromosome 22 in Ewing’s sarcoma. A cytogenetic study of four fresh tumors. Cancer Genet Cytogenet 12:21–25

    Article  CAS  PubMed  Google Scholar 

  7. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O (1993) Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 12:4481–4487

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Urano F, Umezawa A, Yabe H, Hong W, Yoshida K, Fujinaga K, Hata J (1998) Molecular analysis of Ewing’s sarcoma: another fusion gene, EWS-E1AF, available for diagnosis. Jpn J Cancer Res 89:703–711

    Article  CAS  PubMed  Google Scholar 

  9. Shing DC, McMullan DJ, Roberts P, Smith K, Chin SF, Nicholson J, Tillman RM, Ramani P, Cullinane C, Coleman N (2003) FUS/ERG gene fusions in Ewing’s tumors. Cancer Res 63:4568–4576

    CAS  PubMed  Google Scholar 

  10. Barr FG, Womer RB (2007) Molecular diagnosis of Ewing family tumors: too many fusions… ? J Mol Diagn 9:437–440

    Article  PubMed Central  PubMed  Google Scholar 

  11. de Alava E, Kawai A, Healey JH, Fligman I, Meyers P, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PHB, Barr FG, Ladanyi M (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J Clin Oncol 16:1248–1255

    PubMed  Google Scholar 

  12. Hauben E, van den Broek LC, Van Marck E, Hogendoorn PC (2001) Adamantinoma-like Ewing’s sarcoma and Ewing’s-like adamantinoma. The t (11; 22), t (21; 22) status. J Pathol 195:218–221

    Article  CAS  PubMed  Google Scholar 

  13. Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW (2005) Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 29:1025–1033

    PubMed  Google Scholar 

  14. Schuetz AN, Rubin BP, Goldblum JR, Shehata B, Weiss SW, Liu W, Wick MR, Folpe AL (2005) Intercellular junctions in Ewing sarcoma/primitive neuroectodermal tumor: additional evidence of epithelial differentiation. Mod Pathol 18:1403–1410

    Article  CAS  PubMed  Google Scholar 

  15. Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, Karzeladze A, Savelov N, Petrov S, Alvarado-Cabrero I, Mihaila D, Terrier P, Lopez-Guerrero JA, Picci P (2009) Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch 455:397–411

    Article  CAS  PubMed  Google Scholar 

  16. Ishii N, Hiraga H, Sawamura Y, Shinohe Y, Nagashima K (2001) Alternative EWS-FLI1 fusion gene and MIC2 expression in peripheral and central primitive neuroectodermal tumors. Neuropathology 21:40–44

    Article  CAS  PubMed  Google Scholar 

  17. Jimenez RE, Folpe AL, Lapham RL, Ro JY, O’Shea PA, Weiss SW, Amin MB (2002) Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the Kidney. A clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol 26:320–327

    Article  PubMed  Google Scholar 

  18. Karpate A, Menon S, Basak R, Yuvaraja TB, Tongaonkar HB, Desai SB (2012) Ewing sarcoma/primitive neuroectodermal tumor of the kidney: clinicopathologic analysis of 34 cases. Ann Diagn Pathol 16:267–274

    Article  PubMed  Google Scholar 

  19. Gardner LJ, Ayala AG, Monforte HL, Dunphy CH (2004) Ewing sarcoma/peripheral primitive neuroectodermal tumor: adult abdominal tumors with an Ewing sarcoma gene rearrangement demonstrated by fluorescence in situ hybridization in paraffin sections. Appl Immunohistochem Mol Morphol 12:160–165

    Article  PubMed  Google Scholar 

  20. Rekhi B, Qureshi S, Basak R, Desai SB, Medhi S, Kurkure P, Menon S, Maheshwari A, Jambhekar NA (2010) Primary vaginal Ewing’s sarcoma or primitive neuroectodermal tumor in a 17-year-old woman: a case report. J Med Case Rep 4:88

    Article  PubMed Central  PubMed  Google Scholar 

  21. Ostwal V, Rekhi B, Noronha V, Basak R, Desai SB, Maheshwari A, Prabhash K (2012) Primitive neuroectodermal tumor of ovary in a young lady, confirmed with molecular and cytogenetic results-a rare case report with a diagnostic and therapeutic challenge. Pathol Oncol Res 18:1104–1106.

    Google Scholar 

  22. Meier VS, Kühne T, Jundt G, Gudat F (1998) Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations. Diagn Mol Pathol 7:29–35

    Article  CAS  PubMed  Google Scholar 

  23. Yamaguchi U, Hasegawa T, Morimoto Y, Tateishi U, Endo M, Nakatani F, Kawai A, Chuman H, Beppu Y, Endo M, Kurotaki H, Furuta K (2005) A practical approach to the clinical diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumor and other small round cell tumors sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue. J Clin Pathol 58:1051–1056

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A (2006) Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol 19:1–8

    Article  CAS  PubMed  Google Scholar 

  25. Jambhekar NA, Bagwan IN, Ghule P, Shet TM, Chinoy RF, Agarwal S, Joshi R, Amare Kadam PS (2006) Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors. Arch Pathol Lab Med 130:1813–1818

    CAS  PubMed  Google Scholar 

  26. Liu BY, Yang Y, Du J, Zhang Y, Wang H, Zheng J (2008) Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumor. Beijing Da Xue Xue Bao 40:358–362

    CAS  PubMed  Google Scholar 

  27. Gamberi G, Cocchi S, Benini S, Magagnoli G, Morandi L, Kreshak J, Gambarotti M, Picci P, Zanella L, Alberghini M (2011) Molecular diagnosis in Ewing family tumors: the Rizzoli experience–222 consecutive cases in four years. J Mol Diagn 13:313–324

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Vural C, Uluoğlu O, Akyürek N, Oğuz A, Karadeniz C (2011) The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing’s sarcoma family of tumors. Pathol Oncol Res 17:619–625

    Article  CAS  PubMed  Google Scholar 

  29. Qian X, Jin L, Shearer BM, Ketterling RP, Jalal SM, Lloyd RV (2005) Molecular diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol 14:23–28

    Article  CAS  PubMed  Google Scholar 

  30. Bridge JA, Cushman-Vokoun AM (2011) Molecular diagnostics of soft tissue tumors. Arch Pathol Lab Med 135:588–601

    CAS  PubMed  Google Scholar 

  31. Romeo S, Dei Tos AP (2010) Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 456:219–234

    Article  CAS  PubMed  Google Scholar 

  32. Sugimura H, Mori H, Nagura K, Kiyose S, Tao H, Isozaki M, Igarashi H, Shinmura K, Hasegawa A, Kitayama Y, Tanioka F (2010) Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives. Pathol Int 60:543–550

    Article  PubMed  Google Scholar 

  33. Chen H, McClain D, Jhawar SC, Agaram NP, Hameed M (2012) Complex interphase fluorescent in situ hybridization patterns of EWSR1 gene in Ewing sarcoma using break apart probes. Abstract 28. USCAP

  34. Kojima T, Asami S, Chin M, Yoshida Y, Mugishima H, Suzuki T (2002) Detection of chimeric genes in Ewing’s sarcoma and its clinical applications. Biol Pharm Bull 25:991–994

    Article  CAS  PubMed  Google Scholar 

  35. Parija T, Shirley S, Uma S, Rajalekshmy KR, Ayyappan S, Rajkumar T (2005) Type 1 (11; 22) (q24:q12) translocation is common in Ewing’s sarcoma/peripheral neuroectodermal tumor in south Indian patients. J Biosci 303:371–376

    Article  Google Scholar 

  36. Chen N, Zhou Q (2005) Constructing tissue microarrays without prefabricating recipient blocks. A novel approach. Am J Clin Pathol 124:103–107

    Article  CAS  PubMed  Google Scholar 

  37. Machado I, Noguera R, Pellin A, Lopez-Guerrero JA, Piqueras M, Navarro S, Llombart-Bosch A (2009) Molecular diagnosis of ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol 18:189–19938

    Article  CAS  PubMed  Google Scholar 

  38. Perlman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP (1994) Ewing’s sarcoma–routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. Hum Pathol 25:304–307

    Article  CAS  PubMed  Google Scholar 

  39. Folpe AL, Hill CE, Parham DM, O’Shea PA, Weiss SW (2000) Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing’s sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 24:1657–1662

    Article  CAS  PubMed  Google Scholar 

  40. Kavalar R, Pohar Marinsek Z, Jereb B, Cagran B, Golouh R (2009) Prognostic value of immunohistochemistry in the Ewing’s sarcoma family of tumors. Med Sci Monit 15:CR442–CR452

    PubMed  Google Scholar 

  41. Mhawech-Fauceglia P, Herrmann F, Penetrante R, Beck A, Sait S, Block AM, Odunsi K, Fisher J, Balos L, Cheney RT (2006) Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing’s sarcoma/primitive neuroectodermal tumor (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies. Histopathology 49:569–575

    Article  CAS  PubMed  Google Scholar 

  42. Llombart-Bosch A, Navarro S (2001) Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol 9:255–260

    Article  CAS  PubMed  Google Scholar 

  43. Downing JR, Head DR, Parham DM, Douglass EC, Hulshof MG, Link MP, Motroni TA, Grier HE, Curcio-Brint AM, Shapiro DN (1993) Detection of the (11;22)(q24;q12) translocation of Ewing’s sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 143:1294–1300

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Sorensen PH, Liu XF, Delattre O, Rowland JM, Biggs CA, Thomas G, Triche TJ (1993) Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 2:147–157

    Article  CAS  PubMed  Google Scholar 

  45. Dockhorn-Dworniczak B, Schäfer KL, Dantcheva R, Blasius S, Winkelmann W, Strehl S, Burdach S, van Valen F, Jürgens H, Böcker W (1994) Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing’s tumors. Virchows Arch 425:107–112

    Article  CAS  PubMed  Google Scholar 

  46. Guillou L (2008) Contribution of molecular biology and markers to the prognosis and management of patients with soft tissue sarcoma. Pathol Case Rev 13:69–77

    Article  Google Scholar 

  47. Kumar R, Rekhi B, Shirazi N, Pais A, Amare P, Gawde D, Jambhekar N (2008) Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case. Diagn Cytopathol 36:868–875

    Article  PubMed  Google Scholar 

  48. Bridge JA (2008) Contribution of cytogenetics to the management of poorly differentiated sarcomas. Ultrastruct Pathol 32:63–71

    Article  PubMed  Google Scholar 

  49. Diaz LK, Gupta R, Kidwai N, Sneige N, Wiley EL (2004) The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer. J Histochem Cytochem 52:501–507

    Article  CAS  PubMed  Google Scholar 

  50. de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindán FJ, Healey JH, Ladanyi M (2000) Prognostic impact of P53 status in Ewing sarcoma. Cancer 89:783–792

    Article  PubMed  Google Scholar 

  51. Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M (2005) Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 23:548–558

    Article  CAS  PubMed  Google Scholar 

  52. Balamuth NJ, Womer RB (2010) Ewing’s sarcoma. Lancet Oncol 11:184–1192

    Article  CAS  PubMed  Google Scholar 

  53. Pierron G, Tirode F, Lucchesi C, Reynaud S, Ballet S, Cohen-Gogo S, Perrin V, Coindre JM, Delattre O (2012) A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44:461–466

    Article  CAS  PubMed  Google Scholar 

  54. Italiano A, Sung YS, Zhang L, Singer S, Maki RG, Coindre JM, Antonescu CR (2012) High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosome Cancer 51:207–218

    Article  CAS  Google Scholar 

  55. Ladanyi M, Bridge JA (2000) Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 31:532–538

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study (in part) was presented by B.R. at the Association for Molecular Pathologists (AMP) meeting on Genomic Medicine, 2012 at Long Beach, California USA, from 25th October to 27th October, 2012. The support of Immunohistochemistry laboratory of our Department is acknowledged. We thank Smita Mumbarkar, Jyoti Bodke and Rajni Mohite from molecular pathology laboratory, ACTREC, Khargar, Navi Mumbai. We acknowledge Ms Barbara Mankel, Institute of Pathology, University Hospital Tuebingen, Eberhard-Karls-University, Germany for technical support.

Financial disclosure

None.

Conflict of Interest

None.

Author information

Authors and Affiliations

  1. Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, India

    Bharat Rekhi, Ranjan Basak, Sangeeta B. Desai & Nirmala A. Jambhekar

  2. Institute of Pathology, University Hospital Tuebingen, Eberhard-Karls-University, Leibermeisterstrasse 8, 72076, Tuebingen, Germany

    Ulrich Vogel

  3. Division of Molecular Pathology, ACTREC, Navi Mumbai, Khargar, Mumbai, Maharashtra, India

    Bharat Rekhi, Ranjan Basak, Sangeeta B. Desai & Nirmala A. Jambhekar

Authors
  1. Bharat Rekhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ranjan Basak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sangeeta B. Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nirmala A. Jambhekar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bharat Rekhi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rekhi, B., Vogel, U., Basak, R. et al. Clinicopathological and Molecular Spectrum of Ewing Sarcomas/PNETs, Including Validation of EWSR1 Rearrangement by Conventional and Array FISH Technique in Certain Cases. Pathol. Oncol. Res. 20, 503–516 (2014). https://doi.org/10.1007/s12253-013-9721-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9721-2

Keywords

Search

Navigation